20mg Librela Solution for Dogs - 2 Vials
370952
Librela 20mg is a new injecton used for arthritis pain relief in dogs. Librela is scientifically proven to ease pain effectively for an entire month. With minimal liver, kidney, and GI involvement, Librela's monoclonal antibodies offer a safer, more natural approach to treating osteoarthritis in dogs.
Librela provides an innovative alternative to NSAIDs by targeting the Nerve Growth Factor (NGF), known for inducing pain and inflammation in osteoarthritis. Dogs show a marked increase in mobility and reduction in pain after the first dose, making it an ideal choice for pain management. Librela is administered as a subcutaneous injection, usually once a month, by a veterinary surgeon or at home if your Vet has given you some training.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Librela 20mg is a caninised monoclonal antibody. Each vial of 1ml Librela contains 20mg bedinvetmab and enhances the natural process of clearing away immune complexes, thus avoiding pain signals from reaching the brain and causing neuropathic pain.
Osteoarthritis, often referred to as arthritis, is a long-term joint condition that causes pain, stiffness and reduced mobility. Dogs may find it harder to rise after rest, climb stairs, jump into the car, or keep up on walks. Managing pain can help maintain activity and muscle, which supports joint function.
Osteoarthritis commonly affects weight-bearing joints such as hips, elbows and knees, but it can also involve the spine. When a dog moves less due to pain, muscle support reduces and joints can become stiffer, which may worsen the cycle of discomfort. For this reason, long-term management often focuses on keeping movement comfortable and consistent, rather than waiting until a dog is severely lame.
How 20mg Librela works
Librela contains bedinvetmab, a canine monoclonal antibody. A monoclonal antibody is a targeted protein therapy designed to bind to a specific substance in the body. Bedinvetmab targets nerve growth factor (NGF), which is involved in pain signalling and in the "turning up" of pain sensitivity.
In osteoarthritis, NGF activity around affected joints can contribute to ongoing discomfort. When bedinvetmab binds to NGF, it helps reduce NGF‑mediated signalling. This can lower pain signalling from the joint and improve comfort. Librela does not repair cartilage or reverse structural joint changes. It is intended to manage pain so that supportive measures, such as controlled exercise and weight management, are easier to maintain.
Product Features
- Pack Size: - Pack of 2
- Target Animal: - Dog (Canine)
- Related Condition: - Osteoarthritis in Dogs
- Pet Prescription Required?: - Yes
- Active Ingredient: - Bedinvetmab
- Product Name: - Librela solution for injection for dogs
More Information
Description
How Librela works
Librela contains bedinvetmab, which is a canine monoclonal antibody. Monoclonal antibodies are proteins designed to bind to a specific target in the body. Bedinvetmab targets nerve growth factor (NGF), a naturally occurring protein involved in pain signalling. In osteoarthritis, NGF contributes to the transmission and amplification of pain signals from affected joints.
After injection, bedinvetmab binds to NGF and reduces NGF-mediated cell signalling. This can reduce the sensation of osteoarthritis pain. Librela works differently from many traditional pain-relief medicines, such as non-steroidal anti-inflammatory drugs (NSAIDs). Your veterinary surgeon will decide whether Librela is suitable for your dog and how it fits alongside any other treatments.
Response times vary. Some dogs show improvement within the first week, while others need longer. If the response after the first dose is limited, some dogs show additional improvement after a second dose given one month later. If there is still no meaningful benefit after two doses, your veterinary surgeon may recommend an alternative approach.
Librela is supplied in different strengths to match a labelled dosing schedule based on bodyweight. The 20mg vial contains 1 ml of solution and is commonly used for dogs in the 30.1 kg to 40.0 kg bodyweight range, as part of the dosing table. Your veterinary practice will select the most appropriate strength based on an accurate weight.
Librela is not suitable for every dog. It should not be used in dogs under 12 months of age. It should not be used in pregnant or lactating animals, or in animals intended for breeding. It should not be used in dogs with known hypersensitivity to the active substance or excipients. If your dog has other medical conditions, or is taking other medicines, your vet will take this into account when prescribing.
Arthritis (osteoarthritis) in dogs
Canine osteoarthritis is a long-term joint condition that causes pain, stiffness and reduced range of motion. It involves cartilage wear, inflammation within the joint, and changes to surrounding tissues and bone. Osteoarthritis can affect any joint, but hips, elbows, knees, shoulders and the spine are common sites.
Typical causes and risk factors include age, previous injury (such as cruciate ligament disease), hip or elbow dysplasia, and excess bodyweight. Symptoms often fluctuate. Many dogs have a baseline level of stiffness with occasional flare-ups after heavier activity.
Early signs can be subtle. You might notice stiffness when rising, limping, slowing down on walks, reluctance to jump or climb stairs, difficulty getting into the car, or reduced interest in play. Behaviour can also change, including irritability or reduced tolerance of handling around painful joints.
If you suspect arthritis, a veterinary assessment is important. Other problems can look similar, including paw pain, soft tissue injury and neurological conditions. Your vet may diagnose osteoarthritis based on history and examination and may recommend imaging such as X-rays to support the diagnosis and guide treatment.
Managing arthritis
Most dogs benefit from a combined plan that addresses pain and daily movement.
Weight control reduces load on joints and can make a noticeable difference to comfort. Your veterinary practice can advise on an appropriate diet and safe, realistic weight loss where needed.
Regular, controlled exercise is usually better than intense, sporadic activity. Short, steady walks can maintain fitness without repeated flare-ups. If your dog has been inactive due to pain, increases in activity should be gradual.
Physiotherapy and rehabilitation can improve strength and balance. Simple home changes can also help, including non-slip mats, supportive bedding and ramps for steps or cars. Some dogs also benefit from joint-support diets or supplements, chosen with veterinary advice.
Librela can be used as part of a long-term osteoarthritis management plan. Monthly administration can suit dogs that struggle with daily tablets, and it provides a consistent approach that can be reviewed regularly by your vet. Librela may be used on its own or alongside other treatments, depending on your dog’s needs and overall health.
Some dogs with arthritis also receive NSAIDs or other pain-relief medicines. Your veterinary surgeon will decide what combination is appropriate and whether monitoring is needed. Librela should not be mixed with other veterinary medicinal products in the same syringe.
Handling and storage
Librela should be stored and transported refrigerated at 2°C to 8°C. It should not be frozen. It should be kept in the original packaging and protected from light. Once opened, it should be used immediately. If your order is delivered, it should be placed into a refrigerator promptly on arrival.
How quickly does Librela start working?
Some dogs show improvement within the first week, while others need longer. If the response after the first dose is limited, additional improvement may be seen after the second monthly dose. Your vet should review progress and decide whether continuing treatment is appropriate for your dog.
Is Librela a steroid or an NSAID?
Librela is not a steroid and it is not a non-steroidal anti-inflammatory drug (NSAID). It is a monoclonal antibody that binds to nerve growth factor (NGF), which is involved in transmitting pain signals. This different mechanism can be useful in selected dogs under veterinary guidance.
Can Librela be used with other arthritis medicines?
Your vet may use Librela alongside other treatments, depending on your dog’s overall health and response. Some dogs also receive NSAIDs, physiotherapy or other pain-control options. Treatment combinations should be planned by a veterinary surgeon, rather than adding medicines without advice, and reviewed regularly
What side effects can occur with Librela?
Side effects can include mild injection site swelling or warmth. Less commonly, increased thirst and urination, urinary incontinence, unsteadiness, lethargy, diarrhoea, vomiting or reduced appetite can occur. Very rarely, hypersensitivity reactions have been reported. Contact your vet promptly if you are concerned.
How should Librela be stored at home?
Librela should be kept refrigerated at 2°C to 8°C in the original packaging and protected from light. It should not be frozen. If it is delivered to your home, place it in the refrigerator promptly to maintain the cold chain. Follow the label instructions and your veterinary practice’s advice.
You may also like
Arthri-Aid Omega Joint Supplement ArthriAid - 250ml
ArthriAid Omega for Dogs & Cats is an innovative combination of Glucosamine, Chondroitin and MSM plus essential cofactors that helps reduce stiffness, joint pain and discomfort in dogs. This unique formulation also helps to encourage the manufacture of new cartilage and synovial fluid leading to easier joint mobility.
250ml Arthri Aid
100ml Metacam Oral Suspension for Dogs
100ml Metacam (or Meloxicam) is a medicine that can be prescribed by your vet for the treatment of painful inflammatory conditions such as arthritis or soft tissue injuries.
When given as directed, Metacam (meloxicam) helps to reduce prostaglandin levels and is effective in reducing pain associated with osteoarthritis, inflammation due to soft tissue injuries and surgery. VET PRESCRIPTION REQUIRED
Onsior 20mg Tablet for Dogs - per Tablet
20mg Onsior for Dogs is a new fast-acting pain reliever for dogs which concentrates at the site of inflammation. VET PRESCRIPTION REQUIRED
5mg Librela Solution for Dogs - 2 Vials
5mg Librela is an innovative monthly drug for the alleviation of pain associated with osteoarthritis in dogs.
Librela 5mg is a breakthrough solution for dogs suffering from osteoarthritis pain. The treatment effectively relieves discomfort for a whole month, with a safety profile proven through rigorous testing. Librela works uniquely, targeting Nerve Growth Factor (NGF), a significant contributor to osteoarthritis pain, offering a different approach than Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
Librela 5mg uses monoclonal antibodies—immune system proteins that neutralise disease-causing molecules—mirroring naturally occurring antibodies. With minimal involvement of liver or kidneys, it’s a gentle option with a minimal gastrointestinal impact, reducing the potential for adverse reactions.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Clinical trials demonstrated that dogs experienced decreased pain and increased mobility after just one injection. Delivered as a monthly injection at the clinic, Librela ensures the efficient management of osteoarthritis pain.
Librela 5mg contains a canine monoclonal antibody (mAb) which targets nerve growth factor (NGF). This inhibits NGF-mediated cell signalling which has been demonstrated to provide relief from pain associated with osteoarthritis.
10mg Librela Solution for Dogs - 2 Vials
10mg Librela is an innovative drug for the alleviation of pain associated with osteoarthritis in dogs.
Librela 10mg provides an innovative answer to managing the pain of osteoarthritis in dogs. This treatment successfully eases pain for an entire month, assured by its established safety record. Unlike conventional Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Librela's unique mechanism targets Nerve Growth Factor (NGF), a critical factor in osteoarthritis discomfort.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Librela utilises monoclonal antibodies, proteins that form part of the immune system, to neutralise harmful molecules associated with disease. These antibodies act similarly to naturally occurring ones, offering a gentle treatment option with limited liver or kidney involvement and minimal gastrointestinal effect.
15mg Librela Solution for Dogs - 2 Vials
15mg Librela is an innovative drug for the alleviation of pain associated with osteoarthritis in dogs.
Librela 15mg is a revolutionary solution that provides effective relief from osteoarthritis pain in dogs, with a safety profile supported by studies. It differs from traditional NSAIDs by specifically targeting Nerve Growth Factor (NGF), an essential cause of osteoarthritis pain.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Librela is a monoclonal antibody, replicating the function of naturally occurring antibodies. It is removed via standard protein degradation pathways, resulting in a low-impact treatment on the liver or kidneys and minimal gastrointestinal effects. Clinical studies indicate increased mobility and reduced pain in dogs after the initial Librela injection.
30mg Librela Solution for Dogs - 2 Vials
30mg Librela for Dogs is a vet-prescribed monthly injection that targets Nerve Growth Factor (NGF) to relieve osteoarthritis pain in dogs, helping improve comfort, mobility and daily activity at home.
Librela is a refrigerated medication - We will send it via Royal Mail Special Delivery using insulated packaging and ice packs. A signature is required on delivery and it must be put straight into a fridge. We cannot guarantee same day dispatch for orders placed after 12pm. VETERINARY PRESCRIPTION REQUIRED.
Osteoarthritis (Arthritis) is a long-term joint condition. In a healthy joint, smooth cartilage covers the ends of the bones and helps them glide with minimal friction. The joint also contains lubricating fluid and supportive tissues that keep movement stable. With osteoarthritis, cartilage gradually becomes damaged and less effective at cushioning. The joint lining can become inflamed, the joint can thicken, and movement can become painful and stiff. Dogs may avoid using the joint fully, which can lead to reduced muscle strength and poorer joint stability.
Osteoarthritis is common in older dogs, but it can develop at any age. Previous joint injury, repeated strain, and inherited joint conformation issues (such as hip or elbow dysplasia) can all contribute. Excess body weight is also important because it increases the load on painful joints and can worsen stiffness.
Librela 30mg contains bedinvetmab, which is a monoclonal antibody. Monoclonal antibodies are designed to target a specific molecule in the body. Bedinvetmab targets nerve growth factor (NGF), a signalling molecule involved in pain pathways. In osteoarthritis, NGF can contribute to ongoing pain by increasing the sensitivity of nerves in and around affected joints.
Because osteoarthritis is ongoing, Librela is usually repeated every month to help maintain consistent pain control. Your vet may suggest tracking changes in your dog’s daily activity and comfort, because gradual improvements can be easier to spot when you look back over a few weeks. If your dog’s mobility suddenly worsens, if they show new pain, or if you notice any change that concerns you, you should contact your veterinary practice for advice.
BD Discardit 2ml Syringe with 21g Needle - each
This 2ml syringe with an attached 21-gauge (21g) needle is suitable for administering specific medications to cats and dogs that require subcutaneous injections. Each syringe is individually packaged, sterile, and designed for single use only. This product is commonly used in veterinary practices and at home under veterinary guidance.
The syringe has a 2ml capacity and is fitted with a 21g needle. This needle size is considered suitable for administering certain subcutaneous or intramuscular injections in cats and dogs, depending on the medication and the animal’s size and condition. The 21g needle offers a balance between needle strength and minimal discomfort during injection, making it appropriate for routine use with specific veterinary biologics.
This type of syringe is appropriate for administering Solensia, Librela, and Cytopoint, which are injectable monoclonal antibody therapies used to manage chronic pain and allergic dermatitis in pets. These medications are typically prescribed for monthly administration and are given via subcutaneous injection. The 21g needle provides a suitable gauge for delivering the full dose efficiently while maintaining comfort for the animal.
Solensia is prescribed for the management of osteoarthritis pain in cats. It is given once a month via subcutaneous injection. The 2ml syringe allows for accurate dosing, and the 21g needle is appropriate for the viscosity of the Solensia solution and for delivering it under the skin in a cat with minimal stress and tissue trauma.
Librela is used in dogs to treat pain associated with osteoarthritis. Like Solensia, it is administered subcutaneously once a month. The 21g needle is appropriate for most dog breeds and sizes, as it enables smooth delivery of the medication while being strong enough to penetrate the skin effectively without bending or breaking.
Cytopoint is another monoclonal antibody therapy, used to manage allergic dermatitis in dogs. It is also given as a monthly subcutaneous injection. The 2ml capacity of the syringe provides ample volume to accommodate the required dose, and the 21g needle is compatible with the formulation’s consistency and administration method.
This syringe and needle combination should not be used for insulin administration in cats or dogs. Veterinary insulin products such as Caninsulin and Prozinc require specific insulin syringes that are calibrated differently from standard 2ml syringes. Insulin syringes are typically marked in units, not millilitres, and have finer, shorter needles such as 29g or 30g, which are designed to deliver precise insulin doses in small volumes. Using a standard 2ml syringe for insulin injections can lead to inaccurate dosing and can be dangerous to the animal.